Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.28 USD | +8.47% | -3.03% | +122.61% |
22/04 | Chardan Adjusts Price Target on Ocugen to $5 From $4, Maintains Buy Rating | MT |
22/04 | Chardan Raises Price Target on Ocugen to $5 From $4, Keeps Buy Rating | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 329M 27.46B |
---|---|---|---|---|---|
Net income 2024 * | -66M -5.5B | Net income 2025 * | -72M -6B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.57
x | P/E ratio 2025 * |
-4.83
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.51% |
Latest transcript on Ocugen, Inc.
1 day | +8.47% | ||
1 week | -3.03% | ||
Current month | -21.95% | ||
1 month | -21.95% | ||
3 months | +136.56% | ||
6 months | +256.55% | ||
Current year | +122.61% |
Managers | Title | Age | Since |
---|---|---|---|
Shankar Musunuri
CEO | Chief Executive Officer | 60 | 01/13/01 |
Director of Finance/CFO | 42 | - | |
Jesse Simmers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 17/22/17 | |
Director/Board Member | 74 | 05/20/05 | |
Ramesh Kumar
BRD | Director/Board Member | 68 | 27/19/27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1.28 | +8.47% | 5,390,899 |
25/24/25 | 1.18 | 0.00% | 6,861,511 |
24/24/24 | 1.18 | -5.60% | 7,358,032 |
23/24/23 | 1.25 | +0.81% | 6,900,697 |
22/24/22 | 1.24 | -6.06% | 7,685,032 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+122.61% | 329M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- OCGN Stock